Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma

AIMS: To date, curative resection remains to be the most optimal therapeutic choice of hepatocellular carcinoma (HCC), though the overall survival (OS) remains extremely unsatisfactory. To better manage the HCC patients, we evaluated the prognosis predicting values of apolipoprotein B (ApoB) and low...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Xiaotong, Yao, Mingjie, Wen, Xiajie, Zhu, Yiwei, Zhao, Erjiang, Qian, Xiangjun, Chen, Xiangmei, Lu, Weiquan, Lv, Quanjun, Zhang, Ling, Lu, Fengmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420103/
https://www.ncbi.nlm.nih.gov/pubmed/30881047
http://dx.doi.org/10.2147/OTT.S192631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6420103/
https://www.ncbi.nlm.nih.gov/pubmed/30881047
http://dx.doi.org/10.2147/OTT.S192631

Ejemplares similares